Brent L. Larson, EVP, CFO, Treasurer and Sec'y at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), sold 12,500 shares at $1.61 ($20K) on 2015-07-01, disclosed to the SEC on 2015-07-02.
Scheduled sale ($20k) by EVP, CFO, Treasurer and Sec'y under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NAVB | SELL | 2015-10-05 | $28K | — | Filing → |
| NAVB | SELL | 2015-09-02 | $24K | — | Filing → |
| NAVB | SELL | 2015-08-05 | $21K | — | Filing → |